ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

Ono Pharma adding lymphoma to cancer drug's uses

Gyo Sagara

TOKYO -- Ono Pharmaceutical will start selling its Opdivo cancer drug as a blood cancer treatment covered by Japan's health insurance within the year, President Gyo Sagara told The Nikkei on Monday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more